Reata Pharma
(RETA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 7,571 | 32,392 | 9,963 | 12,557 | 12,806 |
| Gross Profit | 7,571 | 32,392 | 9,963 | 12,557 | 12,806 |
| Operating Expenses | 34,223 | 28,136 | 26,489 | 24,575 | 24,000 |
| Operating Income | -26,652 | 4,256 | -16,526 | -12,018 | -11,194 |
| Interest Expense | 903 | 509 | 0 | 484 | 468 |
| Other Income | -650 | 335 | -148 | 195 | 73 |
| Pre-tax Income | -28,205 | 4,082 | -16,674 | -12,307 | -11,589 |
| Income Tax | 6 | N/A | 0 | 1 | 2 |
| Net Income Continuous | -28,211 | 4,082 | -16,674 | -12,308 | -11,591 |
| Net Income | $-28,211 | $4,082 | $-16,674 | $-12,308 | $-11,591 |
| EPS Basic Total Ops | -1.08 | 0.16 | -0.65 | -0.50 | -0.52 |
| EPS Basic Continuous Ops | -1.08 | 0.16 | -0.66 | -0.50 | -0.52 |
| EPS Diluted Total Ops | -1.08 | 0.15 | -0.65 | -0.50 | -0.52 |
| EPS Diluted Continuous Ops | -1.08 | 0.15 | -0.66 | -0.50 | -0.52 |
| EBITDA(a) | $-26,396 | $4,416 | $-16,365 | $-11,886 | $-11,042 |